Millennium Management
PLRX icon

Millennium Management’s Pliant Therapeutics PLRX Stock Holding History

Millennium Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
1,180,518
+771,687
+189% +$974K ﹤0.01% 4114
2025
Q4 		$499K Sell
408,831
-128,506
-24% -$193K ﹤0.01% 4944
2025
Q3 		$795K Sell
537,337
-313,137
-37% -$478K ﹤0.01% 4792
2025
Q2 		$987K Buy
+850,474
New +$1.2M ﹤0.01% 4421
2024
Q4 		– Sell
-244,640
Closed -$2.74M – 6345
2024
Q3 		$2.74M Buy
244,640
+171,350
+234% +$2.14M ﹤0.01% 3405
2024
Q2 		$788K Buy
73,290
+42,751
+140% +$551K ﹤0.01% 4275
2024
Q1 		$455K Buy
+30,539
New +$504K ﹤0.01% 4881
2023
Q4 		– Sell
-181,884
Closed -$3.15M – 6433
2023
Q3 		$3.15M Sell
181,884
-175,679
-49% -$3.05M ﹤0.01% 3159
2023
Q2 		$6.48M Sell
357,563
-14,240
-4% -$337K ﹤0.01% 2416
2023
Q1 		$9.89M Buy
371,803
+165,072
+80% +$4.7M 0.01% 1969
2022
Q4 		$4M Buy
206,731
+12,849
+7% +$269K ﹤0.01% 2999
2022
Q3 		$4.05M Sell
193,882
-26,331
-12% -$504K ﹤0.01% 3106
2022
Q2 		$1.76M Buy
220,213
+162,146
+279% +$1.04M ﹤0.01% 3836
2022
Q1 		$407K Sell
58,067
-6,196
-10% -$63.2K ﹤0.01% 5279
2021
Q4 		$868K Buy
64,263
+30,867
+92% +$491K ﹤0.01% 4536
2021
Q3 		$564K Buy
33,396
+16,077
+93% +$341K ﹤0.01% 5238
2021
Q2 		$504K Sell
17,319
-46,047
-73% -$1.43M ﹤0.01% 5304
2021
Q1 		$2.49M Buy
63,366
+31,570
+99% +$1.03M ﹤0.01% 3319
2020
Q4 		$722K Buy
31,796
+14,648
+85% +$367K ﹤0.01% 3946
2020
Q3 		$388 Sell
17,148
-52,920
-76% -$1.32M ﹤0.01% 3704
2020
Q2 		$2.27M Buy
+70,068
New +$1.86M ﹤0.01% 2429

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Millennium Management's PLRX Position: Q1 2026 in Review

Millennium Management increased its Pliant Therapeutics (PLRX) stake by 189% in Q1 2026, buying an estimated $974K and bringing the position to 1,180,518 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Millennium Management first reported a position in PLRX in Q2 2020 and has held it in 21 quarters since. The position peaked at $9.89M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Millennium Management held 1,180,518 shares of Pliant Therapeutics worth $1.49M as of Q1 2026.
  • Millennium Management bought 771,687 Pliant Therapeutics shares in Q1 2026, an estimated $974K.
  • Pliant Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4114 holding.
  • Millennium Management first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Millennium Management's Pliant Therapeutics position peaked at $9.89M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.